Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.
To determine the net financial gain or loss for herpes zoster vaccination services provided to patients from the perspective of an independent community pharmacy. Retrospective review of pharmacy records over the program's initial 11-month period. Independent community pharmacy in Iowa City, IA. Patients received immunization with the herpes zoster vaccine from a certified pharmacist. Herpes zoster vaccination services were provided to the patient and documented by the pharmacist. Net financial gains or losses were calculated for the herpes zoster vaccination program. Sensitivity analyses were based on costs that might be incurred during program start-up. 478 patients received zoster vaccination services over the initial 11-month period. A net financial gain for the herpes zoster vaccination program was achieved, with a net profit of $15.02, or 8.15%, per vaccination. Revenues for this vaccination program exceeded its costs from the independent community pharmacy perspective.